ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Neptune Pad ® Compared to Conventional Manual Compression

This study has been completed.

Sponsored by: Vienna General Hospital
Information provided by: Vienna General Hospital
ClinicalTrials.gov Identifier: NCT00597363
  Purpose

BACKGROUND. Arterial access site complications remain the most frequent adverse events after percutaneous transluminal procedures. We investigated the safety and efficacy of the pro-coagulant wound dressing Neptune Pad ® compared to conventional manual compression for access site management after peripheral percutaneous interventions.

METHODS. We enrolled 201 consecutive patients and randomly assigned patients for Neptune Pad ® (n=100) vs. conventional manual compression (n=101). Patients were followed clinically until hospital discharge and by duplex ultrasound at 24 hours postprocedure for occurrence of access site complications. Time-to-hemostasis and time-to-ambulation were recorded, patients´ and physicians´ discomfort were measured using a visual analogue scale.


Condition Intervention
Postoperative Hemorrhage
Device: Neptune P.A.D. (R)
Other: conventional manual compression

ChemIDplus related topics:   Calcium gluconate    Alginic acid   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   Neptune Pad ® Compared to Conventional Manual Compression for Access Site Management After Peripheral Percutaneous Transluminal Procedures

Further study details as provided by Vienna General Hospital:

Enrollment:   201
Study Start Date:   January 2006
Study Completion Date:   January 2008
Primary Completion Date:   September 2007 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1: Experimental
Neptune PAD utilization to accelerate closure of the vascular access site
Device: Neptune P.A.D. (R)
The Neptune Pad ® (Biotronik GmbH & Co. KG, Berlin, Germany) is a soft and hydrophilic wound dressing, which has been developed to accelerate local hemostasis, reduce compression times, enable early ambulation and minimize the risk for bleeding complications. Neptune Pad ® consists of calcium alginate, which is cationically charged and exerts potent procoagulant properties.
2: Active Comparator
manual compression for closure of the vascular access site
Other: conventional manual compression
The most common technique for puncture site management is manual compression. This technique requires an extended pressure on the puncture site, and after achievement of hemostasis a pressure bandage is applied for several hours at bed rest.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • All inguinal punctures (common femoral, superficial femoral and deep femoral artery, antegrade and retrograde access) were included.
  • No specific limitations of anti-platelet or anti-coagulant medication were specified.

Exclusion Criteria:

  • Patients with extreme obesity (BMI above 35 kg/m2) were not included according to the manufactures' recommendations.
  • Furthermore, patients with known hypersensitivity to components of the device were not eligible
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00597363

Locations
Austria
General Hospital Vienna    
      Vienna, Austria, 1090

Sponsors and Collaborators
Vienna General Hospital

Investigators
Principal Investigator:     Martin Schillinger, MD     Professor    
  More Information

Publications:

Responsible Party:   Department of Internal Medicine, Division of clinical Angiology, MUW Vienna ( Prof.Dr. Wolfgang Mlekusch )
Study ID Numbers:   EK 433/2004
First Received:   January 9, 2008
Last Updated:   January 17, 2008
ClinicalTrials.gov Identifier:   NCT00597363
Health Authority:   Austria: Agency for Health and Food Safety

Keywords provided by Vienna General Hospital:
vascular access site  
arterial puncture  
femoral pseudoaneurysm  

Study placed in the following topic categories:
Alginic acid
Postoperative Complications
Postoperative Hemorrhage
Hemorrhage

Additional relevant MeSH terms:
Pathologic Processes

ClinicalTrials.gov processed this record on August 29, 2008




Links to all studies - primarily for crawlers